로딩 중…
지수 로딩 중…
FIRST TRACKS BIOTHERAPEUTICS INC
TRAX· NASDAQ· Health Care· Health Care Equipment & Services
$42.51-6.12%
2026-09-03
Financials
Valuation Metrics
FIRST TRACKS BIOTHERAPEUTICS INC's Market Cap is $1.52B. Ranked #2194 of 3,117 in US market (top 70%), #869 of 1,459 on NASDAQ (top 60%), #129 of 205 in Health Care Equipment & Services (top 63%) by Market Cap.
Investment Metrics(as of 2026-09-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.52B | US#2,194/3,117 Sec#129/205 |
| Revenue | $0.00 | US#2,892/3,117 Sec#202/205 |
| Net Income | $-166M | US—/3,117 Sec—/205 |
| Total Assets | $331M | US#2,897/3,117 Sec#172/205 |
| Net Assets | $287M | US#2,542/3,117 Sec#144/205 |
| Employees | 104 | US#2,623/3,117 Sec#182/205 |
| Value | ||
| P/B | 5.28x | US#2,289/3,117 Sec#140/205 |
| FCF Yield | -9.42% | US—/3,117 Sec—/205 |
| Profitability | ||
| ROE | -57.77% | US#2,720/3,117 Sec#174/205 |
| ROA | -50.25% | US#2,996/3,117 Sec#198/205 |
| Financial Health | ||
| Debt Ratio | 14.98% | US#174/3,117 Sec#14/205 |
| Total Debt | $14M | US#2,814/3,117 Sec#181/205 |
| FCF | $-143M | US#2,714/3,117 Sec#196/205 |
| Cash | $238M | US#1,600/3,117 Sec#91/205 |
| Current Ratio | 10.20x | US#250/3,117 Sec#8/205 |
| Performance | ||
| 1M Return | -7.61% | US#1,655/3,117 Sec#141/205 |
| From 52W High | -14.83% | US#830/3,117 Sec#65/205 |
| 1Y MDD | -39.69% | US#2,005/3,117 Sec#114/205 |
| Trading | ||
| Volume | 691,661 shares | US#1,090/3,117 Sec#54/205 |
| Trading Value | $30M | US#1,071/3,117 Sec#71/205 |
| Per Share | ||
| EPS | $-4.65 | US—/3,117 Sec—/205 |
| BPS | $8.05 | US#1,999/3,117 Sec#115/205 |
Company Info
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.